Edralbrutinib (TG-1701) is a potent BTK inhibitor with anticancer activity used in treating tumors, immune system disorders, and blood and lymphatic system disorders. Additionally, Edralbrutinib is studied for its efficacy in membranous glomerulonephritis and optic neuromyelitis optica.
Molekulargewicht:
489.47
Reinheit:
99.47%
CAS Nummer:
[1858206-58-2]
Formel:
C26H21F2N5O3
Target-Kategorie:
BTK
T63272
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten